Introduction/Overview
Natural products have always been an important source of innovative drug discovery, and their structural diversity and wide range of biological activities provide rich chemical entities for modern pharmacological research. Sclareol (CAS number: 515-03-7), as a representative natural compound of diterpenoid diols, has attracted much attention in recent years due to its significant anti-cancer activity and potential neuropharmacological effects. This compound was originally derived from plants of the Salvia genus in the Lamiaceae family Southern European Danshen It was isolated from Salvia sclarea L., commonly known as Perilla frutescens, and its unique chemical skeleton and diverse biological effects have attracted continuous exploration from researchers in the fields of pharmacology, oncology, and neuroscience.
Early studies have confirmed that perilla alcohol exhibits strong cytotoxic activity against various tumor cell lines, including mouse leukemia P-388, human epidermal cancer KB cells, and human leukemia cells, and can effectively induce cell apoptosis. This lays the foundation for it as an anti-tumor lead compound. In addition, recent pharmacological studies suggest that perilla alcohol may exert potential sedative effects by acting on targets such as serotonin transporter (SLC6A4), 5-HT1A receptor (HTR1A), and gamma aminobutyric acid type A receptor (GABAA) subunits (such as GABRA1, GABRB2, GABRG2), opening up new possibilities for its application in the treatment of neurological diseases.
This article aims to provide a systematic review of the chemical properties, plant sources, pharmacological activities, mechanisms of action, medicinal properties, and clinical application prospects of perilla alcohol, in order to provide comprehensive scientific references for the in-depth development and transformation research of this natural product.
Chemical structure and physicochemical properties
The chemical name of perilla alcohol is Rabeprol（Labd-14-ene-8, 13-diol）， Belonging to Labdane type diterpenoid compounds. Its molecular formula is C20H36O2 and its molecular weight is 308.5060. Its core structure is composed of three six membered rings (A/B/C ring) and one five membered ring (D ring) fused together, with one hydroxyl group connected at C-8 and C-13 positions, and one double bond at C-14 position. This rigid multi ring skeleton and specific functional group distribution are the structural basis of its biological activity.
From the analysis of physical and chemical properties, perilla alcohol exhibits typical lipophilic characteristics. The calculated lipid water partition coefficient (LogP) is 4.5488, indicating its high hydrophobicity. This characteristic and its extremely low Water solubility(about 0.0040 mg/mL) is consistent, which poses a challenge for its formulation development. Its topological polar surface area (TPSA) is 40.4600 Å ², which is relatively small, further confirming its non-polar characteristics. It is worth noting that based on its high LogP value and small TPSA, it is predicted to have High blood-brain barrier permeability This provides important pharmacokinetic prerequisites for its potential central nervous system activity, such as sedative effects. Preliminary drug risk assessment shows that it HERG inhibition risk is negative, and The Ames test result is 0.0 This suggests that its potential risk of arrhythmia and genetic toxicity is low, providing preliminary positive signals for its safety as a drug lead compound.
Plant sources and extraction methods
Perilla frutescens mainly comes from plants of the Salvia genus in the Lamiaceae family Southern European Danshen（Salvia sclarea L.）。 This plant has traditionally been used for flavoring, food seasoning, and aromatherapy. Perilla frutescens mainly exists in the volatile oils and resin secretions of the flowers, leaves, and stems of this plant, and is its characteristic aroma component and important secondary metabolite.
The conventional methods for extracting perilla alcohol from plant materials include:
1. steam distillation This is the traditional method for obtaining perilla essential oil. Perilla alcohol, as a non-volatile component in the essential oil, is often precipitated in crystalline form or obtained through subsequent separation. This method is easy to operate, but the yield is relatively low.
2. Organic solvent extraction method Common solvents include petroleum ether, n-hexane, ethyl acetate, ethanol, etc. After crushing the dried plant materials, extraction is carried out using methods such as immersion, Soxhlet extraction, or ultrasound assisted extraction. This method has high extraction efficiency and is a commonly used method for laboratory scale preparation.
3. Supercritical fluid extraction Using supercritical CO2 as the extractant, it has the advantages of high selectivity, no solvent residue, and low operating temperature, especially suitable for the extraction of thermosensitive natural products, and can obtain high-purity perilla alcohol.
4. Column chromatography purification Crude extracts are usually complex in composition and require further purification. Technologies such as silica gel column chromatography, reverse phase silica gel column chromatography, or preparative high-performance liquid chromatography are commonly used for separation and purification to obtain monomer compounds that meet research requirements.
In recent years, biotechnology methods such as plant cell culture and synthetic biology pathways have also been explored, aiming to achieve sustainable and large-scale production of perilla alcohol.
Pharmacological activity research
The pharmacological activity research of perilla alcohol mainly focuses on anti-tumor and central nervous system regulation, demonstrating the potential for multi-target action.
1. Antitumor activity
The anticancer activity of Perilla frutescens alcohol is its most concerned pharmacological characteristic. Numerous in vitro studies have confirmed its broad-spectrum and strong cytotoxic activity against various human tumor cell lines.
- Hematological system tumors It exhibits significant growth inhibition and apoptosis induction effects on mouse leukemia P-388 cells and human leukemia cells (such as HL-60, K562).
- solid tumor: It has obvious inhibitory effect on proliferation of human epidermoid carcinoma KB cells, human lung cancer A549 cells, human breast cancer MCF-7 cells, human colon cancer HCT-116 cells, and human prostate cancer PC-3 cells.
- In vivo research In tumor bearing mouse models, perilla alcohol can effectively inhibit tumor growth, prolong the survival of model animals, and show lower systemic toxicity compared to certain chemotherapy drugs.
2. Sedation and anti anxiety potential
Although related research is still in its early stages, the sedative activity of perilla alcohol has attracted attention based on its predicted high blood-brain barrier permeability and potential effects on specific neural targets. Traditionally, the essential oil derived from the plant Salvia miltiorrhiza in southern Europe is often used in aromatherapy to relax and relieve stress. Modern pharmacology speculates that this effect may be related to its regulation of the GABAergic and serotonergic systems, which is consistent with its known target predictions (GABAA receptor subunits, 5-HT1A receptors). Preliminary animal behavior experiments (such as elevated cross maze and opening experiments) have shown that coumarin or its derivatives may have the effect of reducing anxiety like behavior, but the specific strength and mechanism of the effect need to be further elucidated.
3. Other activities
In addition, the study also reported that perilla alcohol has biological activities such as antibacterial, anti-inflammatory, and anti Leishmania parasites, further expanding its potential application range.
Mechanism of action and molecular targets
The pharmacological effects of perilla alcohol, especially its anti-cancer and potential central effects, involve multiple molecular targets and complex signaling pathway networks.
1. Mechanism of inducing tumor cell apoptosis
This is the core mechanism of its anti-tumor effect. Perilla frutescens alcohol can trigger endogenous (mitochondrial pathway) and exogenous (death receptor pathway) apoptosis in tumor cells through multiple signaling pathways.
- mitochondrial disorder Perilla frutescens alcohol can induce a decrease in mitochondrial membrane potential, promote the release of cytochrome c from mitochondria to cytoplasm, activate caspase-9 and effector caspase-3, and ultimately lead to cell apoptosis.
- Regulating Bcl-2 family proteins It can downregulate the expression of anti apoptotic proteins Bcl-2 and Bcl xL, while upregulating the expression of pro apoptotic proteins Bax and Bak, breaking the balance of apoptosis.
- Death receptor pathway Studies have shown that perilla alcohol can upregulate the expression of death receptors (such as Fas and TRAIL receptors) and their ligands, activate caspase-8, and trigger an apoptotic cascade reaction.
- cell cycle arrest Perilla frutescens alcohol can block tumor cells in G1 or G2/M phase, inhibit cell cycle progression, and its mechanism involves the regulation of cyclins (such as cyclin D1, B1) and cyclin dependent kinases (CDKs).
- Inhibition of survival signaling pathway Perilla frutescens alcohol can inhibit key cell survival and proliferation signaling pathways such as PI3K/Akt and NF - κ B, thereby weakening the anti apoptotic ability of tumor cells.
2. Potential central sedative targets
According to the provided target information, the sedative effect of perilla alcohol may involve:
- GABAA receptor As the main inhibitory neurotransmitter receptor in the brain, the enhancement of the GABAergic system is a common mechanism of action for many sedative hypnotic drugs. Perilla frutescens alcohol may enhance GABA mediated chloride ion influx by acting on specific subunits of GABAA receptors (such as α 1, β 2, γ 2), producing central inhibitory and sedative effects.
- 5-HT1A receptor This receptor is an important member of the serotonergic system, and its agonists typically have anti anxiety and sedative effects. Perilla frutescens alcohol may act as a regulator of 5-HT1A receptors, involved in the regulation of emotions and stress responses.
- Serotonin transporter By affecting the reuptake of 5-HT by SLC6A4, the concentration of 5-HT in the synaptic cleft is indirectly regulated, thereby affecting emotions and arousal states.
These target interactions may collectively form the molecular basis for the potential central sedative effect of perilla alcohol, but the specific binding mode and functional regulation details still need to be experimentally verified.
Evaluation of drug properties and pharmacokinetics
Although perilla alcohol has shown excellent biological activity in vitro, its pharmacological development still faces challenges, and related pharmacokinetic studies are relatively limited.
1. Pharmaceutical advantages
- Preliminary safety assessment is good As mentioned earlier, its hERG inhibition and Ames mutagenicity risk are low, providing a favorable safety starting point for its further development.
- Potential for brain permeability High LogP values and low TPSA indicate good blood-brain barrier penetration ability, which is crucial for the development of central nervous system drugs.
- Clear mechanism of activity The mechanism of inducing apoptosis has been extensively studied, providing direction for mechanism based drug design and optimization.
2. Challenges in drug development
- Very poor water solubility The extremely low water solubility (0.0040 mg/mL) severely limits its oral bioavailability and the development of formulations for intravenous administration. This is one of the main obstacles to its conversion into clinical drugs.
- Metabolism and stability As a natural product, its metabolic pathways, metabolite activity, and chemical stability in the body are not fully understood. Its diterpenoid structure may be easily metabolized by the liver cytochrome P450 enzyme system.
- System exposure and distribution Lack of detailed animal or human pharmacokinetic data, including their absorption, distribution, metabolism, and excretion (ADME) characteristics.
3. Pharmacokinetic research strategies and progress
To overcome its poor water solubility, researchers have tried various strategies:
- Prodrug design Esterify, phosphorylate, or form amino acid conjugates with the hydroxyl groups at positions C-8 and C-13 to enhance water solubility and bioavailability.
- Drug delivery system Using nanotechnology, such as liposomes, nanoemulsions, polymer nanoparticles, solid lipid nanoparticles, etc., to encapsulate perilla alcohol can not only significantly improve its solubility and stability, but also achieve tumor targeted delivery, enhance therapeutic efficacy, and reduce systemic toxicity.
- Pharmacokinetic study Preliminary animal studies have shown that after being encapsulated in nano formulations, the area under the blood concentration time curve (AUC) and half-life (t1/2) of perilla alcohol have been significantly improved, demonstrating more ideal pharmacokinetic characteristics.
Clinical application prospects and prospects
As a multi active natural lead compound, perilla alcohol has broad clinical application prospects, but the transformation still needs to overcome many challenges.
1. Development of anti-tumor drugs
This is the most promising direction. Perilla alcohol can be developed as:
- New chemotherapy drugs: Through structural modification and advanced delivery system, develop injection or oral preparations for the treatment of leukemia, lung cancer, breast cancer, colon cancer and other malignant tumors.
- Chemosensitizer Research has shown that the combination of perilla alcohol and certain traditional chemotherapy drugs (such as cisplatin and doxorubicin) may produce synergistic effects, reverse tumor multidrug resistance, and improve chemotherapy efficacy.
- Tumor Preventive Agents Its antioxidant and anti-inflammatory properties also suggest its potential value in the field of chemoprevention.
2. Development of neurological drugs
Based on its potential sedative, anti anxiety targets, and high brain permeability, coumarin or its derivatives are expected to be developed as:
- New anti anxiety or sedative drugs Used for the treatment of generalized anxiety disorder, insomnia, etc., it may have a mechanism of action and a spectrum of side effects different from benzodiazepines.
- Neuroprotective agent Explore its protective role in neurodegenerative diseases such as Alzheimer's disease or cerebral ischemic injury.
3. Outlook and Future Research Directions
- In depth mechanism research Especially the precise target verification of the pivotal role, signal pathway analysis, and behavioral effect evaluation in the overall animal model.
- structural optimization The system conducts structure-activity relationship research, using semi synthetic or total synthetic methods to improve its water solubility, metabolic stability, and targeting while maintaining activity.
- Advanced Delivery System Continue to deepen research on nanomedicine and targeted agents, achieve precise delivery and controlled release, and improve treatment index.
- Preclinical and clinical research Complete preclinical pharmacological, pharmacokinetic, and toxicological evaluations of the system, and gradually advance to the clinical trial stage to verify its safety and efficacy.
- Multi purpose development In addition to medicinal use, it also has potential applications in the fields of cosmetics (antioxidant, anti-aging), food additives (preservative), and agriculture (biopesticides).
Conclusion
Perilla frutescens alcohol is a natural diterpenoid with significant biological activity discovered from the traditional medicinal plant Salvia miltiorrhiza in southern Europe. Its strong in vitro anti-tumor activity, especially its mechanism of inducing cell apoptosis through multiple pathways, makes it an attractive lead compound in the development of anti-tumor drugs. Meanwhile, its potential targets on the GABAergic and serotonergic systems have opened up new possibilities for its application in the treatment of central nervous system diseases. Although its extremely poor water solubility and unclear in vivo fate constitute the main bottlenecks in its conversion to drugs, these challenges are gradually being overcome through structural modifications in modern medicinal chemistry and advanced delivery technologies in pharmacy. In the future, with a deeper understanding of its mechanism of action, systematic optimization of drug properties, and steady progress in clinical translation, perilla alcohol is expected to transform from an excellent natural product molecule into a new therapeutic drug serving human health, fully demonstrating the eternal value of natural products in innovative drug discovery.
